Inventor
JOHN BLANKENSHIP
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes25%
PatentTitleYear
12,383,601Chimeric antigen receptors and uses thereof202512,275,795Binding molecules against BCMA and uses thereof202511,952,428BCMA chimeric antigen receptors and uses thereof202411,939,389BCMA chimeric antigen receptors and uses thereof202411,608,382BCMA chimeric antigen receptors and uses thereof202311,492,409Binding molecules against BCMA and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to NOVARTIS AG (6)· patent assignee history
2022–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 6 | 2022–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |